Literature DB >> 10616860

Evaluation of urinary Tamm-Horsfall protein in post-menopausal diabetic women.

A A Below1, J Chakraborty, S H Khuder, G D Haselhuhn.   

Abstract

Tamm-Horsfall protein (THP), a glycoprotein produced in the thick ascending limb (TAL) and the early distal convoluted tubule (DCT), is normally excreted in large amounts in urine. Urinary THP may be a useful marker for renal damage. The goal of this research project was to determine the THP excretion in control and diabetic post-menopausal women. Twenty-four hour urine samples were collected from 19 controls and 19 diabetic patients (11 non-insulin dependent diabetic mellitus (non-IDDM) patients, and 8 insulin dependent diabetic mellitus (IDDM) patients). Polyacrylamide gel electrophoresis (PAGE), Western blotting, and enzyme linked immunosorbent assay (ELISA) methods were used. It was determined that urinary THP concentrations were significantly decreased in patients with IDDM compared to patients with non-IDDM and controls. In conclusion, laboratory quantitation of urinary THP may be a useful indicator of cellular abnormalities such as reduced protein (THP) synthesis of the cells of the TAL and early DCT in some IDDM patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616860     DOI: 10.1016/s1056-8727(99)00046-x

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  3 in total

1.  Tamm-Horsfall protein in patients with kidney damage and diabetes.

Authors:  Joana Chakraborty; Angela A Below; Deana Solaiman
Journal:  Urol Res       Date:  2004-05

2.  Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes.

Authors:  Daniela Schlatzer; David M Maahs; Mark R Chance; Jean-Eudes Dazard; Xiaolin Li; Fred Hazlett; Marian Rewers; Janet K Snell-Bergeon
Journal:  Diabetes Care       Date:  2012-01-11       Impact factor: 19.112

3.  Serum uromodulin is associated with impaired glucose metabolism.

Authors:  Andreas Leiherer; Axel Muendlein; Christoph H Saely; Elena Kinz; Eva M Brandtner; Peter Fraunberger; Heinz Drexel
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.